ResMed share price drops despite US$1bn Medifox Dan acquisition

ResMed shares are falling despite announcing a major acquisition…

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ResMed has announced a major acquisition
  • The sleep treatment company has signed an agreement to buy Germany's Medifox Dan for US$1 billion
  • Medifox Dan is a leader in out-of-hospital software solutions

The ResMed Inc (ASX: RMD) share price is falling on Wednesday.

At the time of writing, the sleep treatment company’s shares are down 2% to $29.12.

This is despite the release of an acquisition announcement this morning.

What did ResMed announce?

Overnight, ResMed announced an agreement to acquire Medifox Dan for US$1 billion from leading software and services investor, Hg.

The company notes that Medifox Dan is a German leader in out-of-hospital software solutions for providers in major settings across the care continuum.

The release highlights that Medifox Dan’s German customer base is complementary to the customers of ResMed’s US-based software as a service (SaaS) business. In addition, it builds on ResMed’s existing business in Germany as a leading provider of innovative cloud-connected medical devices that transform care for patients with sleep apnoea and other respiratory conditions.

Management commentary

ResMed’s CEO, Mick Farrell, was very pleased with the deal. He believes it will strengthen the company’s position as a global leader in healthcare software solutions. Farrell said:

With the acquisition of Medifox Dan, a fast-growing and innovative German healthcare software leader, we will expand ResMed’s SaaS business portfolio outside our current base in the U.S. market and strengthen our position as the global leader in healthcare software solutions for lower-cost and lower-acuity care.

Medifox Dan has a strong track record of innovation, fully aligned with our teams at Brightree, MatrixCare, and beyond. Medifox Dan’s customer centricity has built strong and ongoing, growing demand for its software solutions across Germany, and we expect that momentum to continue and strengthen as we become one global team.

Is the ResMed share price good value?

Analysts at Citi have responded to the news by reiterating their buy rating and $35.50 price target on the company’s shares.

Based on the current ResMed share price, this implies potential upside of 22% for investors.

Citi commented:

RMD announced that it will acquire Medifox Dan, a German SaaS solutions provider, for US$1bn or 29x EBITDA pro-forma CY21. This is RMD’s third big acquisition in SaaS space after Brightree (Apr 2016) and MatrixCare (Nov 2018). With this acquisition, RMD will be able to expand its SaaS business footprint outside U.S. RMD said, the acquisition will be EPS accretive in FY23. We make no changes to our forecasts pending closure of transaction (expected in 2Q FY23 end i.e. Dec’22). At current price, RMD is trading at a PE of 29x FY24E, below historical avg of 32x.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Rocket powering up and symbolising a rising share price.
Technology Shares

Why is the Damstra share price soaring 26% on Thursday?

Damstra shares are rocketing higher on Thursday...

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Mergers & Acquisitions

Link share price jumps 7% on beefed up takeover bid

The new takeover offer comes after the board opted not to support the recently reduced offer to acquire the company’s…

Read more »

A rubber stamp stamping the word 'rejected' on a yellow background representing the highest bidder dropping out of the race to acquire Infomedia which is bringing its share price down today
Mergers & Acquisitions

Why is the Infomedia share price falling 5% today?

The highest bidder has dropped out of the battle to take over Infomedia.

Read more »

Woman shaking the hand of a man on a deal.
Bank Shares

Bendigo Bank shares rise after going long on leverage with ANZ lending acquisition

Bendigo and Adelaide Bank has struck a deal with ANZ...

Read more »

Two hands being shaken symbolising a deal.
Mergers & Acquisitions

How many global mega deals involved ASX 200 shares in the first half of 2022?

Deal making among ASX 200 shares helped drive a 25.4% increase in M&A activity in Australia in the first half…

Read more »

A man stands with his arms crossed in an X indicate that not everyone is buying ASX mining shares despite the commodities rally
Mergers & Acquisitions

Link share price drops on takeover rejection

Link has rejected a takeover offer from Dye & Durham...

Read more »

Two men shaking hands on a merger.
Mergers & Acquisitions

HRL share price jumps 10% as board backs takeover from ALS

HRL has accepted ALS' takeover offer...

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Mergers & Acquisitions

Why is the Carsales share price crashing 15% lower today?

Carsales shares are sinking on Wednesday. Here's why...

Read more »